| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Elbasvir 50mg/100mg grazoprevir |
| Brand | Zepatier® |
| Indication | For the treatment of genotypes 1 and 4 chronic HCV infection in patients with Child-Turcotte-Pugh score A (CTPA) |
| Assessment Process | |
| Rapid review commissioned | 10/08/2016 |
| Rapid review completed | 13/10/2016 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended for (EBR/GZR) |